ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.
| # | Date | Company | Ticker | CUSIP | Weight | Shares Held | Market Value |
|---|---|---|---|---|---|---|---|
| 1 | 04/14/2026 | CRISPR THERAPEUTICS AG | CRSP | H17182108 | 10.06% | 2,004,630 (10,212) (0.51%) | $109,913,862.90 |
| 2 | 04/14/2026 | TWIST BIOSCIENCE CORP | TWST | 90184D100 | 9.08% | 1,969,261 (10,032) (0.51%) | $99,211,369.18 |
| 3 | 04/14/2026 | TEMPUS AI INC-CL A | TEM | 88023B103 | 8.38% | 1,991,901 (10,148) (0.51%) | $91,587,607.98 |
| 4 | 04/14/2026 | 10X GENOMICS INC-CLASS A | TXG | 88025U109 | 6.62% | 3,068,405 (15,632) (0.51%) | $72,352,989.90 |
| 5 | 04/14/2026 | BEAM THERAPEUTICS INC | BEAM | 07373V105 | 5.82% | 2,107,977 (10,740) (0.51%) | $63,618,745.86 |
| 6 | 04/14/2026 | PERSONALIS INC | PSNL | 71535D106 | 4.40% | 7,610,094 (38,776) (0.51%) | $48,019,693.14 |
| 7 | 04/14/2026 | ILLUMINA INC | ILMN | 452327109 | 4.33% | 372,845 (1,896) (0.51%) | $47,336,401.20 |
| 8 | 04/14/2026 | NATERA INC | NTRA | 632307104 | 4.28% | 231,370 (1,176) (0.51%) | $46,713,603.00 |
| 9 | 04/14/2026 | INTELLIA THERAPEUTICS INC | NTLA | 45826J105 | 3.77% | 2,884,623 (14,696) (0.51%) | $41,134,723.98 |
| 10 | 04/14/2026 | RECURSION PHARMACEUTICALS-A | RXRX | 75629V104 | 3.73% | 11,911,932 (60,696) (0.51%) | $40,738,807.44 |
| 11 | 04/14/2026 | GUARDANT HEALTH INC | GH | 40131M109 | 3.54% | 470,842 (2,396) (0.51%) | $38,707,920.82 |
| 12 | 04/14/2026 | CAREDX INC | CDNA | 14167L103 | 3.27% | 2,122,393 (10,812) (0.51%) | $35,719,874.19 |
| 13 | 04/14/2026 | ABSCI CORP | ABSI | 9.10E+110 | 3.15% | 11,273,082 (57,440) (0.51%) | $34,382,900.10 |
| 14 | 04/14/2026 | VERACYTE INC | VCYT | 92337F107 | 2.82% | 949,197 (4,836) (0.51%) | $30,791,950.68 |
| 15 | 04/14/2026 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 00650F109 | 2.61% | 2,015,747 (10,268) (0.51%) | $28,482,505.11 |
| 16 | 04/14/2026 | NURIX THERAPEUTICS INC | NRIX | 67080M103 | 2.38% | 1,636,206 (8,336) (0.51%) | $26,032,037.46 |
| 17 | 04/14/2026 | GENEDX HOLDINGS CORP | WGS | 81663L200 | 2.13% | 380,922 (1,940) (0.51%) | $23,228,623.56 |
| 18 | 04/14/2026 | SCHRODINGER INC | SDGR | 80810D103 | 2.08% | 1,986,897 (10,124) (0.51%) | $22,749,970.65 |
| 19 | 04/14/2026 | ARCTURUS THERAPEUTICS HOLDIN | ARCT UQ | 03969T109 | 2.06% | 2,666,411 (13,584) (0.51%) | $22,557,837.06 |
| 20 | 04/14/2026 | BUTTERFLY NETWORK INC | BFLY | 124155102 | 1.95% | 4,984,819 (25,400) (0.51%) | $21,335,025.32 |
| 21 | 04/14/2026 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | 1.88% | 273,614 (1,392) (0.51%) | $20,507,369.30 |
| 22 | 04/14/2026 | COMPASS PATHWAYS PLC | CMPS | 20451W101 | 1.66% | 3,147,698 (16,036) (0.51%) | $18,162,217.46 |
| 23 | 04/14/2026 | PRIME MEDICINE INC | PRME | 74168J101 | 1.57% | 4,675,712 (23,824) (0.51%) | $17,113,105.92 |
| 24 | 04/14/2026 | ATAIBECKLEY INC | ATAI UQ | 04650F101 | 1.44% | 4,160,046 (21,196) (0.51%) | $15,766,574.34 |
| 25 | 04/14/2026 | PACIFIC BIOSCIENCES OF CALIF | PACB | 69404D108 | 1.39% | 10,448,353 (53,240) (0.51%) | $15,150,111.85 |
| 26 | 04/14/2026 | CERUS CORP | CERS | 157085101 | 1.24% | 7,072,156 (36,036) (0.51%) | $13,578,539.52 |
| 27 | 04/14/2026 | 908 DEVICES INC | MASS | 65443P102 | 1.22% | 1,853,390 (9,444) (0.51%) | $13,344,408.00 |
| 28 | 04/14/2026 | BIONTECH SE-ADR | BNTX | 09075V102 | 1.07% | 120,503 (612) (0.51%) | $11,652,640.10 |
| 29 | 04/14/2026 | ELI LILLY & CO | LLY | 532457108 | 1.02% | 11,941 (60) (0.51%) | $11,099,756.55 |
| 30 | 04/14/2026 | GENERATE BIOMEDICINES INC | GENB | 370920100 | 0.56% | 477,995 (2,432) (0.51%) | $6,118,336.00 |
| 31 | 04/14/2026 | QUANTUM-SI INC | QSI | 74765K105 | 0.47% | 6,576,509 (33,508) (0.51%) | $5,186,892.65 |
| 32 | 04/14/2026 | GOLDMAN FS TRSY OBLIG INST 468 | X9USDGSFT | 0.02% | 234,191 (-42,077) (-15.23%) | $234,191.38 |
Discover more from ARK Invest Daily Trades Tracker
Subscribe to get the latest posts sent to your email.
